Market Research Future (MRFR) speculates that the global obesity management market is predicted to garner USD 6.2 billion, grabbing a CAGR of 8.4% throughout the forecast period (2015-2022). Unhealthy eating habits and changing lifestyle are the major factors favoring the market growth. Obesity is referred to as the illness in an individual’s body in which the body gains excessive fat and adversely affects the health and results in diabetes, hypertension, and heart disease. Obesity management comprises services, products, and therapies which helps to reduce and manage weight in patients suffering from obesity.
Free Sample PDF Available Here!! https://www.marketresearchfuture.com/sample_request/2690
The prominent players operating the global obesity management market are Merck Sharp & Dohme Corp. a subsidiary of Merck & Co. Inc. (US), Pfizer Inc. (US), Ethicon Inc. (U.S.), AstraZeneca (UK), Apollo Endosurgery (U.S.), Herbalife Ltd. (U.S.), and F. Hoffmann-La Roche Ltd (Switzerland), GlaxoSmithKline Plc. (UK).
Market Potential and Pitfalls
With unhealthy eating habits and changing lifestyle, the prevalence of obesity is increasing, thereby fostering the market growth across the world. Drug manufacturers are heavily investing in R&D activities in order to develop anti-obesity drugs, thereby influencing the obesity management market to a great extent. Moreover, healthcare solution providers are developing innovative solutions for the healthcare sector. Hospitals are offering surgery options as per the condition and medical history of the patient. Such factors are driving the market growth to a great extent. Growing patient population coupled with the R&D activities by the market giants are highly favoring the market growth. For instance, researchers of the University of Liverpool had introduced a treatment for obesity back in 2015. Factors such as rising initiatives by the market players in collaboration with the government in order to generate awareness regarding the negative impact of obesity on health are predicted to propel the market growth. Additional factors such as increasing awareness of weight management techniques are considered to influence the market growth in the coming years. Moreover, with increasing working population coupled with the growth in nuclear families, the demand for inexpensive, fast food and takeaway meals have increased, thereby triggering the obesity management market throughout the forecast period.
On the contrary, the high availability of low-cost alternatives, the high cost of customization, and post-surgical side effects are considered some of the top barriers likely to disrupt the market growth throughout the appraisal period.
Geographically, the obesity management market spans across regions namely, Europe, North America, Asia Pacific, and Rest-of-the-World (RoW).
Among all the regions, Asia Pacific is considered to expand at a rapid pace and is estimated to retain its dominance. The growth is credited to the lack of physical activity, unhealthy life balance, and poor diet. Moreover, the government is highly focusing on the latest technologies and advanced treatment, which is further initiating R&D activities for the development of new drugs. In this region, China and India are extensively focusing on the market players owing to the increasing purchasing power coupled with a huge patient pool as compared to other economies.
The North American region is likely to project as the largest market for obesity management owing to the presence of an obese population along with advanced treatment options. For instance, as per the CDC, approximately 37.9% of the adults were suffering from obesity from 2013 to 2014. Around 70.7% of the adult population were suffering from overweight.
Global Obesity Management Market: Segmental Analysis
The global obesity management market has been segmented on the basis of prescription, surgery, and lifestyle changes.
By mode of prescription, the obesity management market has been segmented into orlistat (Xenical), lorcaserin (Belviq), phentermine and topiramate (Qsymia), bupropion and naltrexone (Contrave), liraglutide (Saxenda), and others.
By mode of surgery, the obesity management market has been segmented into gastric bypass surgery, laparoscopic adjustable gastric banding (LAGB), biliopancreatic diversion with duodenal switch, and others. Among these, the gastric bypass surgery segment is estimated to be the fastest growing market owing to faster recovery time, improved psychological status, and improved longevity.
By mode of lifestyle changes, the global obesity management market has been segmented into dietary changes, exercise, and others.
Ask for an Amazing Discount at https://www.marketresearchfuture.com/check-discount/2690
2.2 Scope Of The Study
2.2.1 Research Objective
2.3 Market Structure
2.4. Market Segmentation
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
- Market Dynamics
4.4 Mega Trends
4.5 Macroeconomic Indicators
Market Factor Analysis
5.1 Value Chain Analysis
5.2 Porters Five Forces
5.3 Demand & Supply: Gap Analysis
5.4 Pricing Analysis
OBTAIN RESEARCH REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/obesity-management-market-2690
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312